ACSS3 and bladder transitional cell carcinoma: We analyzed the staining intensity of the immunochemistry staining of ACSS3 and found that the staining intensity of ACSS3 was significantly higher in samples from BLCA patients in both stage I and stage II plus stage III (Fig. 5c, d).